RUA Life Sciences (LON:RUA) Trading Up 2.5% – Still a Buy?

RUA Life Sciences plc (LON:RUA)’s share price rose 2.5% during mid-day trading on Wednesday . The stock traded as high as GBX 11.27 ($0.14) and last traded at GBX 11.27 ($0.14). Approximately 36,260 shares traded hands during trading, a decline of 77% from the average daily volume of 156,817 shares. The stock had previously closed at GBX 11 ($0.14).

RUA Life Sciences Stock Up 2.5 %

The company has a debt-to-equity ratio of 5.42, a quick ratio of 7.32 and a current ratio of 9.01. The stock has a 50 day moving average price of GBX 12.35 and a 200 day moving average price of GBX 12.15. The company has a market capitalization of £6.99 million, a P/E ratio of -2.63 and a beta of 1.21.

Insider Buying and Selling at RUA Life Sciences

In other RUA Life Sciences news, insider William D. Brown bought 25,000 shares of the firm’s stock in a transaction on Monday, February 3rd. The shares were acquired at an average cost of GBX 13 ($0.17) per share, for a total transaction of £3,250 ($4,152.82). Corporate insiders own 51.33% of the company’s stock.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.